Next Gen Diagnostics CEO Paul Rhodes Announces Formation of UK Subsidiary, Next Gen Diagnostics UK, Ltd.

Next Gen Diagnostics announced today the formation of its UK subsidiary, Next Gen Diagnostics UK, Ltd. NGD is expanding an office and bioinformatics group based in Cambridge, on the West Campus of the University of Cambridge, where it has developed the field’s most automated integrated pathogen bioinformatics suite and machine learning system. The Cambridge group includes co-founder Professor Julian Parkhill, FRS, of the University of Cambridge along with a growing team of bioinformatics developers, data and ML experts.